SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000926617-23-000050
Filing Date
2023-05-16
Accepted
2023-05-16 16:41:49
Documents
13
Period of Report
2023-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K awh-20230516x8k.htm   iXBRL 8-K 82933
2 EX-10.1 awh-20230516xex10_1.htm EX-10.1 95309
  Complete submission text file 0000926617-23-000050.txt   321498

Data Files

Seq Description Document Type Size
3 EX-101.SCH awh-20230516.xsd EX-101.SCH 2550
4 EX-101.LAB awh-20230516_lab.xml EX-101.LAB 15612
5 EX-101.PRE awh-20230516_pre.xml EX-101.PRE 11194
7 EXTRACTED XBRL INSTANCE DOCUMENT awh-20230516x8k_htm.xml XML 5013
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 23928228
SIC: 2835 In Vitro & In Vivo Diagnostic Substances